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Bone extracellular matrix is a heterogeneous composite material consisting, of an inorganic (or mineral) phase, 
an organic phase and water. In an effort to mimic the mineral environment of bone tissue, we recently employed 
biomineralization and created mineralized biomaterials (1). Our studies showed that these biomineralized 
materials induced osteogenic differentiation of stem cells, including human pluripotent stem cells (which 
includes both embryonic stem cells and induced pluripotent stem cells), even in growth medium devoid of any 
osteogenic inducing molecules (2,3). By employing these mineralized materials, we have studied the molecular 
mechanism through which calcium phosphate minerals support osteogenesis with an emphasis on phosphate 
metabolism (4). Our studies show that extracellular phosphate (resulting from the dissolution of calcium 
phosphate minerals) uptake through solute carrier family 20 phosphate transporter member 1 (SLC20a1) 
supports osteogenic differentiation of human mesenchymal stem cells via adenosine, an ATP metabolite, which 
acts as an autocrine/paracrine signaling molecule through A2b adenosine receptor. Perturbation of SlC20a1 
abrogates osteogenic differentiation by decreasing intra-mitochondrial phosphate and ATP synthesis. Our 
studies further show that the phosphate-ATP-adenosine signaling axis not only promotes osteogenic 
differentiation of multipotent progenitor cells but also inhibits their adipogenic differentiation (5). When implanted 
in vivo, these acellular mineralized biomaterials recruited endogenous cells and induced their differentiation to 
form vascularized bone tissues (6) and also supported donor bone marrow transplantation (7). Leveraging these 
understandings, we are currently studying the pivotal role of Adenosine A2b receptor, a G-protein coupled 
receptor on the cell membrane, in regulating bone-specific cells and treating bone metabolic disorders. In this 
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